We have located links that may give you full text access.
Down-regulation of miR-373 increases the radiosensitivity of lung cancer cells by targeting TIMP2.
BACKGROUND: Radiotherapy is a widely used effective treatment for lung cancer in clinic. MicroRNAs (miRNAs) have been proved to play an important role in radiation response. This study aimed to explore the regulatory role and mechanism of miR-373 in lung cancer cell radiosensitivity.
METHODS: qRT-PCR was used to analyze the expression of miR-373 in lung cancer tissues and cell lines. MiR-373 expression was overexpressed or knocked down by transfection with miR-373 mimic or inhibitor. The effects of miR-373 on cell radiosensitivity, migration and invasion were evaluated by clonogenic assay, migration and invasion assay, respectively. Luciferase reporter assay was used to verify whether TIMP2 was a target gene of miR-373. Expression of TIMP2 and signaling pathway molecules were analyzed by western blot.
RESULTS: MiR-373 was upregulated in lung cancer tissues and cell lines. Overexpression of miR-373 resulted in decreased radiosensitivity and increased migration and invasion of lung cancer cells, whereas miR-373 downregulation got opposite results. Luciferase reporter assay confirmed that TIMP2 was a target gene of miR-373. Knockdown of TIMP2 reversed the effects on radiosensitivity, migration and invasion in miR-373 inhibitor-transfected cells. Mechanistically, we found that miR-373 downregulation inhibited PI3K/AKT and Smad signaling pathways by targeting TIMP2.
CONCLUSIONS: Downregulation of miR-373 increased radiosensitivity and inhibited migration and invasion of lung cancer cells through targeting TIMP2 and thus regulating PI3K/AKT and Smad pathways. MiR-373 might be a potential therapeutic target for the treatment of lung cancer.
METHODS: qRT-PCR was used to analyze the expression of miR-373 in lung cancer tissues and cell lines. MiR-373 expression was overexpressed or knocked down by transfection with miR-373 mimic or inhibitor. The effects of miR-373 on cell radiosensitivity, migration and invasion were evaluated by clonogenic assay, migration and invasion assay, respectively. Luciferase reporter assay was used to verify whether TIMP2 was a target gene of miR-373. Expression of TIMP2 and signaling pathway molecules were analyzed by western blot.
RESULTS: MiR-373 was upregulated in lung cancer tissues and cell lines. Overexpression of miR-373 resulted in decreased radiosensitivity and increased migration and invasion of lung cancer cells, whereas miR-373 downregulation got opposite results. Luciferase reporter assay confirmed that TIMP2 was a target gene of miR-373. Knockdown of TIMP2 reversed the effects on radiosensitivity, migration and invasion in miR-373 inhibitor-transfected cells. Mechanistically, we found that miR-373 downregulation inhibited PI3K/AKT and Smad signaling pathways by targeting TIMP2.
CONCLUSIONS: Downregulation of miR-373 increased radiosensitivity and inhibited migration and invasion of lung cancer cells through targeting TIMP2 and thus regulating PI3K/AKT and Smad pathways. MiR-373 might be a potential therapeutic target for the treatment of lung cancer.
Full text links
Related Resources
Trending Papers
British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults.Gut 2024 April 17
Systemic lupus erythematosus.Lancet 2024 April 18
Should renin-angiotensin system inhibitors be held prior to major surgery?British Journal of Anaesthesia 2024 May
Ventilator Waveforms May Give Clues to Expiratory Muscle Activity.American Journal of Respiratory and Critical Care Medicine 2024 April 25
Acute Kidney Injury and Electrolyte Imbalances Caused by Dapagliflozin Short-Term Use.Pharmaceuticals 2024 March 27
Colorectal polypectomy and endoscopic mucosal resection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2024.Endoscopy 2024 April 27
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app